Methylenetetrahydrofolate reductase (MTHFR): The incidence of mutations C677T and A1298C in the Ashkenazi Jewish population

American Journal of Medical Genetics

Volumn 86, Issue 4, 1999, Pages 380-384

  Rady, Peter L ^a   Tyring, Stephen K ^a   Hudnall, S David ^a   Vargas, Trini ^a   Kellner, Leonard H ^b   Nitowsky, Harold ^b   Matalon, Reuben K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Ashkenazi Jews; MTHFR; Polymorphism; Risk mutations

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GENETIC RISK; HOMOCYSTINURIA; HUMAN; JEW; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ALLELES; GENE FREQUENCY; HETEROZYGOTE; HOMOZYGOTE; HUMANS; JEWS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEW YORK; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS; SPINAL DYSRAPHISM; TEXAS; VASCULAR DISEASES;

EID: 0032822750     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19991008)86:4<380::AID-AJMG13>3.0.CO;2-9     Document Type: Article

References (44)

1. Arruda VK, Siqueira LH, Goncalves MS, von Zuben PM, Soares MC, Menezes R, Annichino-Bizzacchi JM, Costa FF. 1998. Prevalence of the mutation C677→T in the methylenetetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 78:332-335.
2. Camacho Vanegas O, Giusti B, Restrepo Fernandez CM, Abbate R, Pepe G. 1998. Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians. Thromb Haemost 79:883-884.
3. Canfield MA, Annegers JF, Brender JD, Cooper SP, Greenberg F. 1996. Hispanic origin and neural tube defects in Houston/Harris county Texas. I. Descriptive epidemiology. Am J Epidemiol 143:1-11.
4. Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, Rosenblatt DS, Genest J Jr, Rozen R. 1997. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol 17:569-573.
5. Clark ZE, Bowen DJ, Whatley SD, Bellamy MF, Collins PW, McDowell IF. 1998. Genotyping method for methylenetetrahydrofolate reductase (C677T thermolabile variant) using heteroduplex technology. Clin Chem 44:2360-2362.
6. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
7. de Franchis R, Mancini FP, D'Angelo A, Sebastio G, Fermo I, de Stefano V, Margaglione M, Mazzola G, di Minno G, Andria G. 1996. Elevated total plasma homocysteine and 677C→T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet 59:262-264.
8. de Franchis R, Buoninconti A, Mandato C, Pepe A, Sperandeo MP, Del Gado R, Capra V, Salvaggio E, Andria G, Mastroiacovo P. 1998. The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J Med Genet 35:1009-1013.
9. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ. 1995. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56:142-150.
10. Eskes TK. 1998. Open or closed? A world of difference: a history of homocysteine research. Nutr Rev 56:236-244.
11. Franco RF, Araujo AG, Guerreiro JF, Elion J, Zago MA. 1998. Analysis of the 677 C→T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost 79:119-121.
12. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen, R. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
13. Gallagher PM, Meleady R, Shields DC, Tan KS, McMaster D, Rozen R, Evans A, Graham IM, Whitehead AS. 1996. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Circulation 94:2154-2158.
14. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R. 1994. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 7:195-200.
15. Goyette P, Frosst P, Rosenblatt DS, Rozen R. 1995. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/ phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 56:1052-1059.
16. Goyette P, Christensen B, Rosenblatt DS, Rozen R. 1996. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR. Am J Hum Genet 59:1268-1275.
17. Gross R. 1968. Anencephalus and spina bifida Br Med J 3:253.
18. Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S. 1998. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. Atherosclerosis 136:347-354.
19. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. 1996. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9.
20. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. 1991. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 48:536-545.
21. Kluijtmans LA, Wendel U, Stevens EM, van den Heuvel LP, Trijbels FJ, Blom HJ. 1998. Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency. Eur J Hum Genet 6:257-265.
22. Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van Oost BA, den Heijer M, Trijbels FJ, Rozen R, Blom HJ. 1996. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 58:35-41.
23. Koch MC, Stegmann K, Ziegler A, Schroter B, Ermert A. 1998. Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr 157:487-492.
24. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R. 1996. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in U.S. physicians. Circulation 94:2410-2416.
25. Matalon RK, Tyring SK, Rady P, Hudnall DS, Vargas T, Nitowsky H, Kellner LH. 1999. Methylenetetrahydrofolate reductase (MTHFR): high incidence of mutation G677T in the Ashkenazi Jewish population. Pediatr Res 45:140A.
26. Molloy AM, Mills JL, Kirke PN, Ramsbottom D, McPartlin JM, Burke H, Conley M, Whitehead AS, Weir DG, Scott JM. 1998. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am J Med Genet 78:155-159.
27. Mornet E, Muller F, Lenvoise-Furet A, Delezoide AL, Col JY, Simon-Bouy B, Serre JL. 1997. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 100:512-514.
28. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
29. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley GP Jr, Adams MJ Jr. 1996. 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 28:610-614.
30. Papapetrou C, Lynch SA, Burn J, Edwards YH. 1996. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 348:58.
31. Refsum H, Ueland PM. 1998. Recent data are not in conflict with homocysteine as a cardiovascular risk factor. Curr Opin Lipidol 9:533-539.
32. Reinhardt D, Sigusch HH, Vogt SF, Farker K, Muller S, Hoffmann A. 1998. Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery disease. Eur J Clin Invest 28:20-23.
33. Rozen R. 1996. Molecular genetics of methylenetetrahydrofolate reductase deficiency. J Inherit Metab Dis 19:589-594.
34. Rozen R. 1997. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 78:523-526.
35. Sacchi E, Tagliabue L, Duca F, Mannucci PM. 1997. High frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in Northern Italy. Thromb Haemost 78:963-964.
36. Salomon O, Moisseiev J, Rosenberg N, Vidne O, Yassur I, Zivelin A, Treister G, Steinberg DM, Seligsohn U. 1998. Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion. Blood Coagul Fibrinolysis 9:617-622.
37. Stevenson RE, Schwartz CE, Du YZ, Adams MJ Jr. 1997. Differences in methylenetetrahydrofolate reductase genotype frequencies between Whites and Blacks. Am J Hum Genet 60:229-230.
38. Thuillier L, Chadefaux-Vekemans B, Bonnefont JP, Kara A, Aupetit J, Rochette C, Montalescot G, Couty MC, Kamoun P, Ankri A. 1998. Does the polymorphism 677C-T of the 5,10-methylenetetrahydrofolate reductase gene contribute to homocysteine-related vascular disease? J Inherit Metab Dis 21:812-822.
39. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051.
40. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, Mariman EC, den Heyer M, Rozen R, Blom HJ. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
41. Verhoef P, Kok FJ, Kluijtmans LA, Blom HJ, Refsum H, Ueland PM, Kruyssen DA. 1997. The 677 A-T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 132:105-113.
42. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. 1998. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169-172.
43. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM. 1995. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 88:763-766.
44. Wilcken DE, Wang XL, Sim AS, McCredie RM. 1996. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol 16: 878-882.